Literature DB >> 17115288

Marginal zone lymphoma of both spleen and kidney displaying transformation into large B-cell lymphoma.

A Canelhas1, E Compérat, A Le Tourneau, T Molina, M Ramos, P Ribeiro, A Pimenta, J Diebold, J Audouin.   

Abstract

We report a case of simultaneous involvement of the spleen and the left kidney in a marginal zone lymphoma with a monotypic lymphoplasmacytic cell component, which transformed into a diffuse large B-cell lymphoma of the immunoblastic type. PCR showed that the small and large B-cell populations carried the same type of immunoglobulin heavy chain gene rearrangement. This type of rearrangement was detected in the spleen, the latero-aortic lymphadenopathy and the kidney demonstrating that it is the same lymphoma that affected both organs and the lymph nodes. Primary renal lymphoma is very rare and only a few cases of renal marginal zone lymphoma, MALT type, have been reported. Involvement of simultaneous multiple sites has been described in MALT type lymphoma, but splenic involvement secondary to renal MALT lymphoma seems to have never been observed. Nevertheless, in our case the huge size of the spleen associated with splenic hilar node involvement is consistent with primary splenic marginal zone lymphoma. The extension into latero-aortic lymph nodes of this lymphoma can explain secondary kidney involvement. The nodal Kaposi's sarcoma observed in this patient of Mediterranean origin was probably coincidental.

Entities:  

Mesh:

Year:  2006        PMID: 17115288     DOI: 10.1007/s11255-006-6658-3

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  15 in total

Review 1.  Primary renal lymphoma does exist: case report and review of the literature.

Authors:  G Stallone; B Infante; C Manno; N Campobasso; G Pannarale; F P Schena
Journal:  J Nephrol       Date:  2000 Sep-Oct       Impact factor: 3.902

2.  Indolent behaviour of low-grade B cell lymphoma of mucosa-associated lymphoid tissue arising in the kidney.

Authors:  B Jindal; S C Sharma; A Das; A K Banerjee
Journal:  Urol Int       Date:  2001       Impact factor: 2.089

3.  Primary MALT lymphoma of the kidney.

Authors:  M Colović; J Hadzi-Djokić; V Cemerikić; R Colović; G Janković; M Dacić
Journal:  Hematol Cell Ther       Date:  1999-11

4.  Primary renal lymphoma: a rare neoplasm that may present as a primary renal mass.

Authors:  Asad H Ahmad; Gregory T Maclennan; Catherine Listinsky
Journal:  J Urol       Date:  2005-01       Impact factor: 7.450

5.  Primary mucosa-associated lymphoid tissue lymphoma in the renal pelvis.

Authors:  Koji Mita; Yoshio Ohnishi; Toru Edahiro; Toshihiro Fujii; Akihiko Yamasaki; Fumio Shimamoto
Journal:  Urol Int       Date:  2002       Impact factor: 2.089

6.  Splenic marginal zone lymphoma with or without plasmacytic differentiation.

Authors:  J P Duong Van Huyen; T Molina; A Delmer; J Audouin; A Le Tourneau; R Zittoun; A Bernadou; J Diebold
Journal:  Am J Surg Pathol       Date:  2000-12       Impact factor: 6.394

7.  Primary renal lymphoma of mucosa-associated lymphoid tissue.

Authors:  Emre Tuzel; M Ugur Mungan; Kutsal Yorukoglu; Alper Basakci; Ziya Kirkali
Journal:  Urology       Date:  2003-02       Impact factor: 2.649

8.  Patterns of bone marrow involvement in 58 patients presenting primary splenic marginal zone lymphoma with or without circulating villous lymphocytes.

Authors:  Josée Audouin; Agnès Le Tourneau; Thierry Molina; Sophie Camilleri-Broët; Colette Adida; Eva Comperat; Laurence Benattar; Alain Delmer; Alain Devidas; Bernard Rio; Jacques Diebold
Journal:  Br J Haematol       Date:  2003-08       Impact factor: 6.998

Review 9.  Primary malignant lymphoma of the kidney: case report and literature review.

Authors:  M J Fernandez-Aceñero; M Galindo; O Bengoechea; P Borrega; J J Reina; R Carapeto
Journal:  Gen Diagn Pathol       Date:  1998-04

10.  Lymphoma of the kidney. A report of 11 cases.

Authors:  J A Ferry; N L Harris; N Papanicolaou; R H Young
Journal:  Am J Surg Pathol       Date:  1995-02       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.